Physician profile
Christopher M Wicker
NPI 1801912829
$4,403.56
in general payments reported to CMS, 2019-2025
41 companies · $874 in 2025
The $874 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $850 · 2020: $183 · 2022: $612 · 2023: $1,080 · 2024: $805 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,758.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $614.61 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $571.69 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $376.32 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Amgen INC. | $295.51 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $219.09 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $202.94 | 2023-2025 | Ingrezza |
| Abbvie INC. | $201.34 | 2019-2025 | Vraylar, Qulipta |
| Novartis Pharmaceuticals Corporation | $186.58 | 2019-2024 | |
| Daiichi Sankyo INC. | $163.46 | 2020-2025 | Injectafer |
| Sanofi-Aventis U.S. LLC | $154.57 | 2019-2025 | |
| Abbott Laboratories | $153.81 | 2019-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.60 | 2019-2025 | Xifaxan, Trulance |
| Exact Sciences Corporation | $103.25 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $84.93 | 2019-2023 | Spravato |
| Glaxosmithkline, LLC. | $76.70 | 2019-2025 | Trelegy Ellipta, Bexsero |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wicker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.